Association of research and development investments with treatment costs for new drugs approved from 2009 to 2018
OJ Wouters, LA Berenbrok, M He, Y Li… - JAMA network …, 2022 - jamanetwork.com
Importance Drug companies frequently claim that high prices are needed to recoup
spending on research and development. If high research and development costs justified …
spending on research and development. If high research and development costs justified …
Patent term restoration for top-selling drugs in the United States
Highlights•Most new drugs receive a patent term restoration (PTR) extension.•Patents with
PTR commonly expire more than 12 years after marketing approval.•Patents with PTR …
PTR commonly expire more than 12 years after marketing approval.•Patents with PTR …
The characteristics of patents impacting availability of biosimilars
The characteristics of patents impacting availability of biosimilars | Nature Biotechnology
Skip to main content Thank you for visiting nature.com. You are using a browser version …
Skip to main content Thank you for visiting nature.com. You are using a browser version …
Market exclusivity length for drugs with new generic or biosimilar competition, 2012–2018
Brand‐name drugs have periods of market exclusivity before generic competition begins.
Due to high brand‐name drug prices charged during this period, market exclusivity is an …
Due to high brand‐name drug prices charged during this period, market exclusivity is an …
Analysis of patent and regulatory exclusivity for novel agents in China and the United States: a cohort study of drugs approved between 2018 and 2021
X Luo, L Yang, X Du, J Yang, F Qian… - Clinical Pharmacology …, 2022 - Wiley Online Library
Patent and regulatory exclusivity shall constitute incentives for pharmaceutical companies to
develop new drugs. This study aims to investigate the differences in the patent term …
develop new drugs. This study aims to investigate the differences in the patent term …
Pre-market development times for biologic versus small-molecule drugs
RF Beall, TJ Hwang, AS Kesselheim - Nature Biotechnology, 2019 - nature.com
3. Regalado, A. More than 26 million people have taken an at-home ancestry test. MIT
Technology Review https://www. technologyreview. com/s/612880/more-than-26-million …
Technology Review https://www. technologyreview. com/s/612880/more-than-26-million …
The prevalence of drug patent term extensions in the United States, 2000–2018
The prevalence of drug patent term extensions in the United States, 2000–2018 | Nature
Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …
Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …
[HTML][HTML] Reimagining pharmaceutical market exclusivities: should the duration of guaranteed monopoly periods be value based?
Objectives To describe the main features of a pharmaceutical market in which the duration of
guaranteed monopoly periods would correspond to a new pharmaceutical product's value …
guaranteed monopoly periods would correspond to a new pharmaceutical product's value …
Authorized generics vs. branded generics: a perspective
B Latwal, A Chandra - Journal of Generic Medicines, 2021 - journals.sagepub.com
Nowadays, there are many generic medications available in the market. Their sale is
increasing day by day due to their lower cost and affordability by most of the customers …
increasing day by day due to their lower cost and affordability by most of the customers …
US spending associated with transition from daily to 3-times-weekly glatiramer acetate
BN Rome, FA Tessema… - JAMA internal medicine, 2020 - jamanetwork.com
Importance Market exclusivity for daily injections of glatiramer acetate, a disease-modifying
therapy for multiple sclerosis, expired in 2015. In 2014, the manufacturer launched an …
therapy for multiple sclerosis, expired in 2015. In 2014, the manufacturer launched an …